Literature DB >> 7603742

Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.

P B Bethwaite1, B Delahunt, L J Holloway, A Thornton.   

Abstract

Previous workers have used counts of colloidal silver-stained nucleolar organizer regions (AgNORs) to help distinguish reactive from malignant mesothelial processes. We sought to compare the demanding technique of AgNOR counting with the identification of proliferating cell nuclear antigen (PCNA) in 10 pleural malignant mesotheliomas and 11 reactive mesothelial proliferations. The mean AgNOR count was significantly higher in malignant compared to reactive lesions (5.10 [95% confidence interval, CI 4.35-5.84] vs 3.68 [95% CI 3.17-4.19], p = 0.004), as was the PCNA index (26.9 [95% CI 17.37-36.49] vs 9.67 [95% CI 4.94-14.39], p = 0.004). Less overlap was seen with PCNA indices and no reactive mesothelial proliferations had a PCNA index greater than 20%, suggesting that scores over this level may be a specific indicator of malignancy in this setting. There was only a weak correlation between the 2 proliferation indices suggesting that PCNA and AgNORs are present at somewhat different times of the cell cycle and/or persist in the post-S phase cell for variable lengths of time.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603742     DOI: 10.1080/00313029500169362

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  2 in total

Review 1.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

2.  Evaluation of cell proliferation in malignant and potentially malignant oral lesions.

Authors:  Mani Madan; Shaleen Chandra; Vineet Raj; Rohit Madan
Journal:  J Oral Maxillofac Pathol       Date:  2015 Sep-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.